Plain-English translation of NCT05887661 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a surgical technique called hypovolemic phlebotomy during minimally invasive liver surgery for patients with hepatocellular carcinoma (liver cancer). About 30 minutes before the surgeon removes the diseased part of the liver, an anesthesiologist will withdraw a small amount of blood from a vein to lower the pressure in your blood vessels. The goal is to see if this technique helps reduce the need for blood transfusions during and after surgery.
Liver surgery can cause significant bleeding, which often requires blood transfusions. This trial is exploring whether the new blood management technique can help minimize blood loss and reduce how many patients need transfusions, potentially making surgery safer and more efficient.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will undergo laparoscopic (minimally invasive) liver surgery at the hospital. You will be randomly assigned to either receive the blood-removal technique before surgery or to have surgery without it (the standard approach). Your surgical team will monitor your blood pressure and fluid levels carefully throughout the procedure. The trial will track how much blood you lose, whether you need a transfusion, and how well you recover after surgery.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
China